Venaxis, a US-based in vitro diagnostic firm, has completed the patient enrollment in its pivotal clinical study of the APPY1 test in the US. The APPY1 test, a unique appendicitis test, has projected high sensitivity and negative ...
Tags: Venaxis, APPY1, Steve Lundy, FDA
Integra LifeSciences, has announced the completion of patient enrollment in a pivotal clinical trial designed to assess the safety and effectiveness of Integra dermal regeneration template in the treatment of diabetic foot ulcers. Integra ...
Duke University’s Duke Clinical Research Institute (DCRI) has been selected by Oxygen Biotherapeutics, a pharmaceutical company, to conduct the Phase III clinical trial of the company’s newly acquired compound, levosimendan. ...
US-based Surefire Medical has completed enrollment in the Coiling vs. Surefire infusion system in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits of performing Selective Internal ...
Tags: Surefire Medical, infusion system, enrollment, COSY, SIRT
US-based CEL-SCI has obtained an approval from the Health Protection Administration, Ministry of Health, of the Croatian Republic to begin patient enrollment in Phase III clinical trial of its investigational cancer immunotherapy treatment, ...
Germany-based medical technology company MagForce has installed a NanoActivator at the University Hospital Munster. This NanoActivator has been installed at the University Hospital Munster as part of the preparations for the new ...
Tags: Glioblastoma study, NanoActivator, NanoTherm therapy, therapy
UK-based GlySure has completed patient enrollment for the multicenter CE Mark trial of its in-hospital continuous blood glucose monitoring (CBGM) system. The trial, led by principal investigator Dr Krishna Prasad, comprised 30 post ...
Tags: CE Mark Trial, Glysure
Colibri Heart Valve announced that patient enrollment has concluded in the first-in-human study of the Company's transcatheter aortic valve implantation (TAVI) system in the Dominican Republic trial site. Analysis of the data from ...
Tags: Colibri Heart Valve, Tavi System
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
Israel-based Cardiosonic announced it is currently enrolling patients in the TIVUS II clinical trial, designed to assess the safety, efficacy and performance of its TIVUS system using a next generation multidirectional catheter. TIVUS ...
Tags: Cardiosonic, Clinical Trial
CardioFocus, developer of the HeartLight endoscopic ablation system (EAS) for the treatment of atrial fibrillation (AF), has concluded enrollment of its US pivotal trial evaluating the HeartLight system, for the treatment of symptomatic ...
US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...
Tags: Insulin Application, biopharmaceutical company MannKind
Vital Access, a provider of surgical and interventional technologies, has launched SAVE-2 post-market clinical follow-up study to investigate the benefits of VWING vascular needle guide for self-cannulation. The SAVE-2 study follows the ...
US-based Intact Vascular has completed the patient enrollment in the Tack Optimized Balloon Angioplasty (TOBA) study, a multi-center study designed to collect confirmatory data on the use of Tack-It Endovascular System in the superficial ...
Tags: Medicine, Patient Enrollment
US-based in vitro diagnostic company Venaxis announced that the Data and Safety Monitoring Board (DSMD) has recommended the continuation of pivotal clinical trial of the APPY1 test, a multiple biomarker-based assay for identifying patients ...
Tags: Appy1 Test, Clinical Trial